Immune cell residency in the nasal mucosa may partially explain respiratory disease severity across the age range
Abstract Previous studies focusing on the age disparity in COVID-19 severity have suggested that younger individuals mount a more robust innate immune response in the nasal mucosa after infection with SARS-CoV-2. However, it is unclear if this reflects increased immune activation or increased immune...
Main Authors: | Konner Winkley, Dithi Banerjee, Todd Bradley, Boryana Koseva, Warren A. Cheung, Rangaraj Selvarangan, Tomi Pastinen, Elin Grundberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-95532-3 |
Similar Items
-
Humoral immune responses during SARS-CoV-2 mRNA vaccine administration in seropositive and seronegative individuals
by: Elizabeth Fraley, et al.
Published: (2021-07-01) -
A temperature-adjusted developmental timer for precise embryonic staging
by: Konner Winkley, et al.
Published: (2018-06-01) -
Angiogenesis in the nasal mucosa
by: Ahmed, Shahzada Khuram
Published: (2013) -
Lymphocyte Differentiation in the Nasal Mucosa
by: M. Gelardi, et al.
Published: (2007-09-01) -
Identification of Pannexins in Rat Nasal Mucosa
by: Toyoaki Ohbuchi M.D., et al.
Published: (2013-09-01)